A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.

Transfer rumors, news: Liverpool turn to Atalanta's Lookman
- 3 hours ago

Pakistan, India will find solution themselves: Trump's response to rising tension
- 39 minutes ago

Could this $10 weightlifting supplement be a depression treatment?
- 2 hours ago

The real quest for fake blood
- 2 hours ago

Heat wave forecast in country from today
- 36 minutes ago

Gen Z is finding religion. Why?
- 2 hours ago

Uber users can now earn miles with Delta Air Lines
- 4 hours ago

Andor’s second season traces the long arc of Star Wars’ revolutionary history
- 4 hours ago

Let’s not panic about AI’s energy use just yet
- 2 hours ago

Tesla’s revenue and profits tank amid political chaos
- 4 hours ago

Who should control OpenAI? Humanity.
- 2 hours ago

US offers Saudi Arabia $100bn defense deal
- 31 minutes ago